In the world of AIDS fraud it's a case of "choose your poison."

Switching Class Inhibitors Might Save Your Life

"Switching from one kind of inhibitor to another to treat your HIV could decrease your risks of developing diabetes, obesity, or heart disease, according to a study published recently in the Journal of Antimicrobial Chemotherapy.

The study participants, who were virally suppressed thanks to antiretroviral regimens that included Truvada (tenofovir disoproxil fumarate/emtricitabine) and a ritonavir-boosted protease inhibitor, were switched instead to regimens with an integrase inhibitor (either raltegravir or dolutegravir) and saw improvement in insulin sensitivity, insulin resistance, and serum leptin levels.}

https://www.hivplusmag.com/treatment/2019/5/02/switching-class-inhibitors-might-save-your-life

Please support HHV-6 University by purchasing one or our books about the cover-up of the relationship between HHV-6 and Chronic Fatigue Syndrome, AIDS, and many other immunological illnesses. Click book to read a free excerpt.